title: Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 analyzer.
abstract: The PI3-kinase/Akt pathway is an important cell survival pathway that is deregulated in the majority of human cancers. Despite the apparent druggability of several kinases in the pathway, no specific catalytic inhibitors have been reported in the literature. The authors describe the development of a fluorometric imaging plate reader (FLIPR)-based Akt1 translocation assay to discover inhibitors of Akt1 activation. Screening of a diverse chemical library of 45,000 compounds resulted in identification of several classes of Akt1 translocation inhibitors. Using a combination of classical in vitro assays and translocation assays directed at different steps of the Akt pathway, the mechanisms of action of 2 selected chemical classes were further defined. Protein translocation assays emerge as powerful tools for hit identification and characterization.
authors.affiliation: BioImage A/S, Copenhagen, Denmark.
authors.forename: Betina Kerstin
authors.initials: BK
authors.lastname: Lundholt
authors.forename: Viggo
authors.initials: V
authors.lastname: Linde
authors.forename: Frosty
authors.initials: F
authors.lastname: Loechel
authors.forename: Hans-Christian
authors.initials: HC
authors.lastname: Pedersen
authors.forename: Søren
authors.initials: S
authors.lastname: Møller
authors.forename: Morten
authors.initials: M
authors.lastname: Praestegaard
authors.forename: Ivan
authors.initials: I
authors.lastname: Mikkelsen
authors.forename: Kurt
authors.initials: K
authors.lastname: Scudder
authors.forename: Sara Petersen
authors.initials: SP
authors.lastname: Bjørn
authors.forename: Morten
authors.initials: M
authors.lastname: Heide
authors.forename: Per O G
authors.initials: PO
authors.lastname: Arkhammar
authors.forename: Robert
authors.initials: R
authors.lastname: Terry
authors.forename: Søren Jensby
authors.initials: SJ
authors.lastname: Nielsen
mesh_terms: D000818:Animals; D016466:CHO Cells; D045744:Cell Line, Tumor; D006224:Cricetinae; D004353:Drug Evaluation, Preclinical / Q000295:instrumentation* / Q000379:methods*; D005470:Fluorometry; D006801:Humans; D015394:Molecular Structure; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D021381:Protein Transport; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins; D051057:Proto-Oncogene Proteins c-akt; C494918:AKT1 protein, human